Marinomed Biotech AG | WebDisclosure

Basculer en Français

8404	Companies
122661	Keywords
61083	Articles
65859	Press releases

Home
Companies
Marinomed Biotech AG

BRIEF

published on 12/19/2024 at 12:44, 11 days 5 hours ago

Marinomed Biotech AG approuve la vente de sa division Carragelose

Marinomed Biotech AG Orientation Stratégique Changements Au Sein Du Conseil D'administration Approbation De La Vente Division De Carragelose
BRIEF

published on 12/19/2024 at 12:44, 11 days 5 hours ago

Marinomed Biotech AG Approves Sale of Carragelose Division

Board Changes Strategic Focus Marinomed Biotech AG Sale Approval Carragelose Division
PRESS RELEASE

published on 12/19/2024 at 12:39, 11 days 6 hours ago

Marinomed Biotech AG: Extraordinary general meeting approves sale of Carragelose division
Marinomed Biotech AG's extraordinary general meeting approves sale of Carragelose division, ensuring implementation of restructuring plan. Dr. Karl Mahler elected to the Supervisory Board

Supervisory Board Marinomed Biotech AG Restructuring Plan Sale Approval Carragelose Division
BRIEF

published on 12/17/2024 at 13:05, 13 days 5 hours ago

Marinomed Biotech AG franchit une étape importante dans sa restructuration

Obligation Convertible Financement Des Biotechnologies Vente De Carraghénose Restructuration De Marinomed Accord BEI
BRIEF

published on 12/17/2024 at 13:05, 13 days 5 hours ago

Marinomed Biotech AG Achieves Restructuring Milestone

Convertible Bond Carragelose Sale Marinomed Restructuring EIB Agreement Biotech Finance
PRESS RELEASE

published on 12/17/2024 at 13:00, 13 days 5 hours ago

Marinomed Biotech AG: Requirements for successful completion of the restructuring proceedings achieved
Marinomed Biotech AG successfully meets requirements for restructuring with funds deposited for cash quota & legal costs. European Investment Bank standstill agreement secured for completion. Sale of Carragelose business to ensure sustainable existence

Restructuring Marinomed Biotech AG Financial Stability Carragelose Sale EIB Agreement
BRIEF

published on 12/05/2024 at 14:39, 25 days 4 hours ago

Marinomed Biotech AG Announces Second Capital Increase

Investment Capital Increase Share Issuance Marinomed Biotech AG Financial Strategy
BRIEF

published on 12/05/2024 at 14:39, 25 days 4 hours ago

Marinomed Biotech AG annonce sa deuxième augmentation de capital

Investissement Stratégie Financière Augmentation De Capital Marinomed Biotech AG Émission D'actions
PRESS RELEASE

published on 12/05/2024 at 14:34, 25 days 4 hours ago

EQS-Adhoc: Marinomed Biotech AG resolves second capital increase excluding statutory subscription rights by issuing 83,750 no-par value bearer shares at an issue price of EUR 8 per share
Marinomed Biotech AG resolves second capital increase by issuing 83,750 bearer shares at EUR 8 per share, excluding subscription rights

Capital Increase Marinomed Biotech AG Subscription Rights 83,750 Shares EUR 8
BRIEF

published on 11/27/2024 at 13:39, 1 month 3 days ago

Marinomed Biotech AG Agrees to Convertible Bond Issuance with EIB

Shareholder Rights Marinomed Biotech AG Convertible Bond European Investment Bank Corporate Action

Accesswire

Published on 12/30/2024 at 18:00, 43 minutes ago

Trust Consulting Services AI Center of Excellence Shifts Focus to Digital Workforce Development in 2025
Published on 12/30/2024 at 17:00, 1 hour 43 minutes ago

Levity Products to Join Arab Health Expo 2025
Published on 12/30/2024 at 15:00, 3 hours 43 minutes ago

Western Alaska Minerals Announces Grant of Options and Restricted Share Units
Published on 12/30/2024 at 14:30, 4 hours 13 minutes ago

Abasca Resources Engages Understood Mineral Resources Ltd. to Complete Flake Graphite Resource Estimate of its Loki Flake Graphite Zone and Grants Stock Options
Published on 12/30/2024 at 13:00, 5 hours 43 minutes ago

SMX is Redefining Ethical Sourcing, KYC, and Data Security in a Tech-Driven World of Fashion and Electronics

View all ACCESSWIRE

EQS Group

Published on 12/30/2024 at 17:45, 58 minutes ago

Eighteenth acquisition in 2024: Mutares has signed an agreement to acquire Nervión Industries, Engineering and Services, S.L.U. from Amper S.A.
Published on 12/30/2024 at 16:50, 1 hour 52 minutes ago

EQS-Adhoc: OTI Greentech AG: Resignation of the chair of the supervisory board
Published on 12/30/2024 at 16:16, 2 hours 26 minutes ago

EQS-Adhoc: OTI Greentech AG: Application for delisting from the open market of the Düsseldorf Stock Exchange resolved
Published on 12/30/2024 at 15:56, 2 hours 46 minutes ago

Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Published on 12/30/2024 at 15:55, 2 hours 48 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Spirent Communications plc

Les Echos

Published on 12/30/2024 at 18:15, 28 minutes ago

Icade - PR - Binding agreement signed between Icade and Casino
Published on 12/30/2024 at 18:15, 28 minutes ago

Icade - CP - Signature d'un accord ferme entre Icade et Casino
Published on 12/30/2024 at 18:00, 43 minutes ago

Groupe CRIT : Finalisation de la transmission générationnelle du contrôle. Information relative au nombre total des droits de vote et d’actions composant le capital social.
Published on 12/30/2024 at 17:45, 58 minutes ago

Disclosure of trading in own shares from December 23th, 2024, to December 27th, 2024. Detailed information per transaction
Published on 12/30/2024 at 17:45, 58 minutes ago

Déclaration des transactions sur actions propres réalisées du 23 décembre 2024 au 27 décembre 2024. Présentation détaillée transaction par transaction

View all LES ECHOS COMFI WIRE